Pharma news
Americas
Eli Lilly has entered into a settlement agreement with generic companies Teva Pharmaceuticals and Watson Laboratories to resolve pending patent litigation over its drug Cialis. 18 July 2017
Pharma
DLA Piper has hired patent litigator Philipp Cepl as a partner in its German patent practice. 17 July 2017
Americas
A New Jersey judge has ruled today that Dr Reddy’s Laboratories infringed a patent owned by Horizon Pharma. 17 July 2017
Pharma
The Federal Court of Justice, Germany’s Supreme Court, has upheld a lower court’s ruling that granted a preliminary compulsory licence to use a patent protecting an HIV treatment. 13 July 2017
Pharma
The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement. 12 July 2017
Americas
The patent system in the US and the EU is not rewarding complex research into treatments for a host of prevalent diseases and conditions, and reforms are going in the wrong direction, says Erika Lietzan of the University of Missouri School of Law. 12 July 2017
Pharma
Precision medicine has come a long way since the completion of the Human Genome Project in 2003, but how have IP regimes developed in this area, asks Sheena Linehan of Potter Clarkson. 12 July 2017
Pharma
The Italian Patent and Trademark Office’s Board of Appeal has ruled that there are no rules preventing the office from adjudicating requests to limit the term of supplementary protection certificates. 12 July 2017
Pharma
The products made by GQ Life Sciences, based in Boston, make IP-related sequence searching easier for scientists, patent searchers and practitioners, as senior product manager Ellen Sherin tells LSIPR. 8 July 2017
Pharma
The UK Supreme Court has ruled that Actavis’s generic versions of cancer drug Alimta directly infringe patents owned by Eli Lilly, reversing two earlier decisions. 7 July 2017